COMPASS THERAPEUTICS INC (CMPX) Stock Analyst Earnings Estimates
NASDAQ:CMPX - Nasdaq - US20454B1044 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A 613.39% | N/A 711.62% | N/A 279.56% | N/A 78.55% | N/A 52.95% | N/A 70.41% | N/A 154.35% | N/A 63.71% | |||||||
| EBITDA YoY % growth | -36.39M | -31.93M 12.26% | -25.41M 20.42% | -81.31M -219.99% | -40.88M 49.72% | -49.664M -21.49% | N/A -10.35% | N/A -2.28% | N/A 16.73% | N/A 23.86% | N/A 324.28% | N/A 104.30% | N/A 58.98% | N/A | N/A | |
| EBIT YoY % growth | -38.31M | -34.05M 11.12% | -27.81M 18.33% | -81.88M -194.43% | -41.66M 49.12% | -50.363M -20.89% | N/A -10.43% | N/A -17.96% | N/A -2.97% | N/A 105.62% | N/A 3,790.23% | N/A 77.15% | N/A 117.19% | N/A 244.34% | N/A 67.93% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | -0.37 69.70% | -0.34 8.11% | N/A -4.62% | N/A -13.30% | N/A -8.19% | N/A 142.57% | N/A 316.65% | N/A 78.56% | N/A 101.18% | N/A 205.80% | N/A 48.32% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.10 11.79% | -0.09 -14.75% | -0.09 5.14% | -0.10 -22.40% | -0.08 14.33% | -0.09 | -0.08 13.98% | -0.05 47.92% | -0.02 75.46% |
| Revenue Q2Q % growth | -100.00% | N/A | N/A | 2.806M | 11.223M | ||||
| EBITDA Q2Q % growth | -14.204M 3.34% | -12.73M -0.90% | -13.219M 10.31% | -14.688M -24.58% | -15.055M -6.00% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -14.473M 5.98% | -14.387M -12.66% | -15.415M -2.46% | -16.423M -34.18% | -13.819M 4.52% | -13.748M 4.45% | -13.175M 14.53% | -11.515M 29.88% | -4.816M 65.15% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.08 | -0.12 | 0.04 | 30.79% |
| Q2 2024 Q2Q % growth | -0.10 -11.11% | -0.10 | 0.00 | -3.20% |
| Q1 2024 Q2Q % growth | -0.08 -33.33% | -0.12 | 0.04 | 30.51% |
| Q4 2023 Q2Q % growth | -0.11 -10.00% | -0.10 | -0.01 | -14.56% |
| Q3 2023 Q2Q % growth | -0.08 33.33% | -0.11 | 0.03 | 26.80% |
| Q2 2023 Q2Q % growth | -0.09 -12.50% | -0.08 | -0.01 | -8.36% |
| Q1 2023 Q2Q % growth | -0.06 14.29% | -0.11 | 0.05 | 45.82% |
| Q4 2022 Q2Q % growth | -0.10 52.38% | -0.11 | 0.01 | 12.85% |
| Q3 2022 Q2Q % growth | -0.12 -20.00% | -0.11 | -0.01 | -10.29% |
| Q2 2022 Q2Q % growth | -0.08 | -0.09 | 0.01 | 6.95% |
| Q1 2022 Q2Q % growth | -0.07 | -0.11 | 0.04 | 37.61% |
| Q4 2021 Q2Q % growth | -0.21 | -0.07 | -0.14 | -182.57% |
| Q3 2021 Q2Q % growth | -0.10 | -0.13 | 0.03 | 21.57% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 3.63% | 22.57% | 1.16% | 17.29% |
| Revenue | N/A | N/A | 0% | -0.97% |